SCHEMBL10618795

SCHEMBL10618795

COc1c(F)oc(Cn2ccnc2S)c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9622057 0.74 DBH (0.51) —
SCHEMBL9621820 0.69 DBH (0.54) —
SCHEMBL9622071 0.66 CYP1A2 (0.51) —
SCHEMBL10593660 0.64 ALDH1A1 (0.50) —
SCHEMBL9400818 0.63 DBH (0.44) —
SCHEMBL9836342 0.63 RAB9A (0.48) —
SCHEMBL9838171 0.63 HPGD (0.37) —
SCHEMBL10618829 0.63 — —
SCHEMBL10618793 0.62 HPGD (0.36) —
SCHEMBL10593221 0.62 LPO (0.58) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0285356-A2 Dopamine-beta-hydroxylase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1988-10-05 — — EP disclosed
Send feedback